Evidence map›Paper›PMID 31634398›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting.

Hannah M Garcia Garrido, Anne M R Mak, Ferdinand W N M Wit, Gino W M Wong, Mirjam J Knol, Albert Vollaard, Michael W T Tanck, Arie Van Der Ende, Martin P Grobusch, Abraham Goorhuis

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. HIV-1 andmSphere · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Asplenia and spleen hypofunction.Nature reviews. Disease primers · 2022
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hannah M Garcia GarridoCenter for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam, The Netherlands.
Anne M R MakCenter for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam, The Netherlands.
Ferdinand W N M WitDutch HIV Monitoring Foundation (Stichting HIV Monitoring), Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, The Netherlands.
Gino W M WongCenter for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam, The Netherlands.
Mirjam J KnolCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Albert VollaardCenter for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Michael W T TanckDepartments of Clinical Epidemiology, Biostatistics and Bioinformatics, and , Amsterdam, The Netherlands.
Arie Van Der EndeMedical Microbiology, Amsterdam UMC, University of Amsterdam, and , Amsterdam, The Netherlands.
Martin P GrobuschCenter for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam, The Netherlands.
Abraham GoorhuisCenter for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam, The Netherlands.
National Institute for Public Health and the Environment · NLAmsterdam University Medical Centers · NLNetherlands Bioinformatics Centre · NLStichting HIV Monitoring · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough people living with human immunodeficiency virus (PLWH) are at increased risk of invasive pneumococcal disease (IPD) and community-acquired pneumonia (CAP), it is unclear whether this remains the case in the setting of early initiation of combination antiretroviral therapy (cART), at high CD4 cell counts. This is important, as pneumococcal vaccination coverage in PLWH is low in Europe and the United States, despite longstanding international recommendations.

methodsWe identified all CAP and IPD cases between 2008 and 2017 in a cohort of PLWH in a Dutch HIV referral center. We calculated incidence rates stratified by CD4 count and cART status and conducted a case-control study to identify risk factors for CAP in PLWH receiving cART.

resultsIncidence rates of IPD and CAP in PLWH were 111 and 1529 per 100 000 patient-years of follow-up (PYFU). Although IPD and CAP occurred more frequently in patients with CD4 counts <500 cells/μL (incidence rate ratio [IRR], 6.1 [95% confidence interval, 2.2-17] and IRR, 2.4 [95% confidence interval, 1.9-3.0]), the incidence rate in patients with CD4 counts >500 cells/μL remained higher compared with the general population (946 vs 188 per 100 000 PYFU). All IPD isolates were vaccine serotypes. Risk factors for CAP were older age, CD4 counts <500 cells/μL, smoking, drug use, and chronic obstructive pulmonary disease.

conclusionsThe incidence of IPD and CAP among PLWH remains higher compared with the general population, even in those who are virally suppressed and have high CD4 counts. With all serotyped IPD isolates covered by pneumococcal vaccines, our study provides additional argumentation against the poor current adherence to international recommendations to vaccinate PLWH.

Indexed as

HIV InfectionsPneumococcal InfectionsPneumoniaPneumonia, PneumococcalAgedCase-Control StudiesEuropeHIVHumansIncidencePneumococcal VaccinesRisk FactorsPneumococcal Vaccinescommunity-acquired pneumoniaepidemiologyHIVpneumococcal diseasevaccination

Identifiers

PMID31634398
PMCPMC7312213
OpenAlexW2982242308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.